Search results
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 6 days agoFurther, the companies are running a late-stage study in non-small cell lung cancer patients. One...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 3 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Moderna Investors Just Got Some Bullish News
The Motley Fool via AOL· 3 days agoBut in later pandemic days, investors started worrying about Moderna's dependence on its only commercialized product, and that has weighed on the stock...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 3 days agoCan Moderna bounce back for investors who buy the dip? To find out, let's look at some reasons the ...
FDA advisors unanimously agree on COVID JN.1-lineage vaccine for fall (NYSE:PFE)
Seeking Alpha· 12 hours agoA panel of advisors unanimously agrees on the need for a monovalent COVID-19 shot targeting the JN.1...
Moderna (NASDAQ:MRNA) Stock Price Down 6.2%
ETF DAILY NEWS· 7 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) shares fell 6.2% during trading on Tuesday . The company traded as low as $156.15 and last traded at $156.26. 873,085 shares ...
The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
Investor's Business Daily· 7 days agoModerna stock seesawed Thursday after confirming the U.S. government is nearing a deal to fund its...
Moderna's mRNA bird flu vaccine trial is close to getting U.S. government funding
Quartz· 7 days agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1...
Moderna just got FDA approval for its RSV vaccine — only its second product on the market
Quartz· 6 days agoThe Food and Drug Administration on Friday approved Moderna’s mRNA-based respiratory syncytial virus...
Health Care Stocks Climb On Drug News -- Health Care Roundup
Market Watch· 5 days agoThe Food and Drug Administration approved Moderna's vaccine to protect against respiratory syncytial virus, a common virus that is among the leading causes of U.S. hospitalizations ...